

Cytogen Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.60 M
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -16.34%
- Profit Growth 102.71%
- Ebitda 99.44%
- Net Worth 148.26%
- Total Assets 4.18%
About Cytogen Pharmaceuticals (India)
Cytogen Pharmaceuticals (India) Private Limited (CPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2003 and has a history of 21 years and five months. Its registered office is in Delhi, India.
The Corporate was formerly known as Cytogen Pharmacuticals (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.60 M, as per Ministry of Corporate Affairs (MCA) records.
Venkatasatyasiva Bhupathiraju, Jhansirani Nadimpalli, and Jayapal Garapati serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239DL2003PTC123455
- Company No.
123455
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Dec 2003
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Cytogen Pharmaceuticals (India) Private Limited offer?
Cytogen Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Protein Supplements, Amino Acids.
Who are the key members and board of directors at Cytogen Pharmaceuticals (India)?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkatasatyasiva Bhupathiraju ![]() | Director | 26-Oct-2020 | Current |
Jhansirani Nadimpalli ![]() | Director | 26-Oct-2020 | Current |
Jayapal Garapati ![]() | Whole-Time Director | 12-Nov-2020 | Current |
Financial Performance of Cytogen Pharmaceuticals (India).
Cytogen Pharmaceuticals (India) Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.34% decrease. The company also saw a substantial improvement in profitability, with a 102.71% increase in profit. The company's net worth Soared by an impressive increase of 148.26%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Cytogen Pharmaceuticals (India)?
In 2022, Cytogen Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Rici Chem Private Limited
Jhansirani Nadimpalli is a mutual person
- Neovation Life Sciences India Private Limited
Jhansirani Nadimpalli is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Cytogen Pharmaceuticals (India)?
Unlock and access historical data on people associated with Cytogen Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Cytogen Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytogen Pharmaceuticals (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Cytogen Pharmaceuticals (India)
Recent activity within the organization
- Annual General Meeting
Cytogen Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Cytogen Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
- Director Appointment
Jayapal Garapati was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 12 Nov 2020 & has been associated with this company since 4 years 5 months .
- Director Appointment
Venkatasatyasiva Ramakrishnaraju Bhupathiraju was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 4 years 6 months .
- Director Appointment
Jhansirani Nadimpalli was appointed as a Director was appointed as a Director on 26 Oct 2020 & has been associated with this company since 4 years 6 months .
- Company Incorporation
Cytogen Pharmaceuticals (India) Private Limited was registered on 10 Dec 2003 with Roc Delhi & aged 21 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Cytogen Pharmaceuticals (India) Private Limited?
Cytogen Pharmaceuticals (India) Private Limited was incorporated on 10 Dec 2003.
What is authorized share capital and paid-up capital of Cytogen Pharmaceuticals (India) Private Limited?
The authorized share capital of Cytogen Pharmaceuticals (India) Private Limited is ₹ 2.50 M and paid-up capital is ₹ 1.60 M.
Who are the current board members & directors of Cytogen Pharmaceuticals (India) Private Limited?
Currently 3 directors are associated with Cytogen Pharmaceuticals (India) Private Limited.
- Venkatasatyasiva Ramakrishnaraju Bhupathiraju
- Jhansirani Nadimpalli
- Jayapal Garapati
What is the registered address of Cytogen Pharmaceuticals (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Cytogen Pharmaceuticals (India) Private Limited is A-8 Block-B-1 First Floor Mohan Corporate Industrial Estate, Mathura Road India, New Delhi, 110044.
What is the corporate identification number (CIN) and company number of Cytogen Pharmaceuticals (India) Private Limited?
The corporate identification number (CIN) of Cytogen Pharmaceuticals (India) Private Limited is U24239DL2003PTC123455 and the company number is 123455 as per Ministry of Corporate Affairs (MCA).
What is the official website of Cytogen Pharmaceuticals (India) Private Limited?
The Official website of Cytogen Pharmaceuticals (India) Private Limited is https://www.cytogenpharma.com
What has been the recent revenue trend for Cytogen Pharmaceuticals (India) Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Cytogen Pharmaceuticals (India) Private Limited has fallen by -16.34%.
What change has been observed in the net worth of Cytogen Pharmaceuticals (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Cytogen Pharmaceuticals (India) Private Limited has experienced an upsurge of 148.26%.
When was the last Balance Sheet of Cytogen Pharmaceuticals (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Cytogen Pharmaceuticals (India) Private Limited was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Raj MallickDirector
SB
Sarv BehlDirectorTG
Tarun GargDirectorSK
Sanjeev KansalDirectorKB
Kailash BehlDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India